Company
New Opportunities with ABX-CRO in New Delhi
In September 2023 ABX-CRO opened its new office in New Delhi, India.
Indian scientific and medical environment and institutions are developing fast and are equipped with modern technology and imaging equipment.
The interest in modern diagnostic and therapeutic methods as well as well-trained and enthusiastic people are the reasons for establishing a new ABX-CRO office here.
Our services in India
- Top level medical & scientific institutions
- Untapped patient populations
- Highest quality clinical operations
- Modern imaging equipment
- Integrated CDMO solutions
- Comprehensive regulatory and administrative support
- Established international and domestic logistics
ABX-CRO’s expert in India
Taranjit Singh is leading our new office in India.
As promoter and owner of B J Madan & Co he has extensive experience in the pharmaceutical and healthcare business and is specialised in bringing to market precursors for PET and SPECT, chemistry for production of cyclotron-based molecules and peptides.
In 2010 he stepped into the world of Theranostics by introducing Ge68/Ga68 Generator into India, and establishing PRRT with Therapeutic Agents like Lu-177, Bi-213 Generator, Ac-225, Pb-203 & Pb-212.
His comprehensive experience and expertise in the field of radiopharmaceuticals makes him perfect to address your needs in planning, setting up, and executing Clinical Trials in India.
Interested in starting a new study in India?
ABX-CRO’s quality management is certified according to ISO 9001:2015 as well as ISO 13485:2016.
ABX-CRO advanced pharmaceutical services
Forschungsgesellschaft mbH
Schössergasse 19
01067 Dresden · Germany
E-mail: info[at]abx-cro.com
Telephone: +49 351 21444-0
Telefax: +49 351 21444-15
© ABX-CRO advanced pharmaceutical services Forschungsgesellschaft mbH
ABX-CRO’s quality management is certified according to ISO 9001:2015 as well as ISO 13485:2016.
ABX-CRO advanced pharmaceutical services
Forschungsgesellschaft mbH
Schössergasse 19
01067 Dresden · Germany
E-mail: info[at]abx-cro.com
Telephone: +49 351 21444-0
Telefax: +49 351 21444-15
© ABX-CRO advanced pharmaceutical services Forschungsgesellschaft mbH